Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study
Cardiooncology. 2024 Feb 6;10(1):5.
doi: 10.1186/s40959-024-00205-5.
1 Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.
2 Department of Internal Medicine, Division of Cardiology, Saint Louis University Hospital, St. Louis, MO, USA.
3 Department of Internal Medicine, Section of Hematology/Oncology, Rush University Medical Center, Chicago, IL, USA.
4 Department of Internal Medicine, Division of Cardiology, Rush University Medical Center, 1717 West Congress Parkway | Kellogg Bldg, Suite 328, Chicago, IL, 60612, USA.
5 Department of Internal Medicine, Division of Cardiology, Rush University Medical Center, 1717 West Congress Parkway | Kellogg Bldg, Suite 328, Chicago, IL, 60612, USA. [email protected].